Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Endometrial Neoplasms × Aromatase Inhibitors × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Arthralgia 2 Osteoporosis 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 Hormone-receptor-positive Breast Cancer 1 Fractures, Bone 1 Fatigue 1 Endometrial Neoplasms 1 Advanced Breast Cancer 1

Interventions

Surveys and Questionnaires 14 Blood Specimen Collection 7 Observation 5 Surgical Procedures, Operative 4 Hysteroscopy 4 Hysterectomy 4 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Ultrasonography 2 Specimen Handling 2 Sentinel Lymph Node Biopsy 2 Reverse Transcriptase Polymerase Chain Reaction 2 Psychiatric Rehabilitation 2 Laparoscopy 2 Immunohistochemistry 2 Data Collection 2 trastuzumab deruxtecan 1 semaglutide 1 sarcolipin 1 rubitecan 1 olaparib 1 dostarlimab 1 X-Rays 1 Vaginal Smears 1 Tissue Banks 1 Therapeutics 1 Tamoxifen 1 Sutures 1 Sonazoid 1 Ropivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03621904 2023-01-18

PROMOTE

Radboud University Medical Center

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡